'Back-Door' Base Closures
Biden Talks Loss With Fallen Troops' Families
Neely Out at GSA
More USPS Buyouts
Gimme My Discount! Deals for Feds
Buyout Watch: Who's Offering What
House committee approves biodefense measure
- By Kristen A. Lee
- September 21, 2006
- Comments
The Biodefense and Pandemic Vaccine and Drug Development Act of 2006 (H.R. 5533), expands on Project BioShield, which was signed into law two years ago.
The bill establishes a point of authority in the federal government -- the Biomedical Advanced Research and Development Authority -- to coordinate and facilitate efforts to develop countermeasures for bioterrorism or pandemic infectious diseases.
The legislation, which passed on voice vote, also authorizes $160 million in fiscal 2007 and fiscal 2008 for advanced research and development.
Rep. Anna Eshoo, D-Calif., who co-sponsored the legislation with Rep. Mike Rogers, R-Mich., cited the threat of avian influenza or another anthrax attack as reasons for the bill's passage.
House Energy and Commerce Health Subcommittee Chairman Nathan Deal, R-Ga., offered a substitute amendment that made technical changes to the bill. The manager's amendment also passed by voice vote.
By using this service you agree not to post material that is obscene, harassing, defamatory, or otherwise objectionable. Although GovExec.com does not monitor comments posted to this site (and has no obligation to), it reserves the right to delete, edit, or move any material that it deems to be in violation of this rule.
